INSL3 in the muscolo-skeletal system.
Hypogonadism
INSL3
Leydig cells
Osteoporosis
RXFP2
Sarcopenia
Journal
Molecular and cellular endocrinology
ISSN: 1872-8057
Titre abrégé: Mol Cell Endocrinol
Pays: Ireland
ID NLM: 7500844
Informations de publication
Date de publication:
01 05 2019
01 05 2019
Historique:
received:
05
11
2018
revised:
27
12
2018
accepted:
31
12
2018
pubmed:
10
1
2019
medline:
16
1
2020
entrez:
10
1
2019
Statut:
ppublish
Résumé
Bone and skeletal muscle are currently considered a unified functional unit, showing complementary regulation at mechanical, biochemical, paracrine and metabolic levels. This functional unit undergoes a central hormonal regulation which is mainly ascribed to sex steroids and, in particular, androgens. However, recent evidence suggest that another testicular hormone lines the classical anabolic effect of testosterone on bone and muscle, the insulin-like peptide 3 (INSL3) acting on its specific receptor RXFP2. This minireview focuses on the most recent findings describing the role of INSL3/RXFP2 axis on the muscolo-skeletal system, from the mechanistic insights to the phenotypic consequences. Pathophysiological and therapeutic widenings deriving from available data are also discussed.
Identifiants
pubmed: 30625346
pii: S0303-7207(18)30382-4
doi: 10.1016/j.mce.2018.12.021
pii:
doi:
Substances chimiques
Insulin
0
Leydig insulin-like protein
0
Proteins
0
Receptors, G-Protein-Coupled
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
12-17Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.